Fatty liver in people with and without HIV
Part of Immune system & allergy, Infections clinical trials.
This study looks at fat buildup in the liver (fatty liver disease) in people with and without HIV. It uses blood tests to understand the liver's fat content and how it relates to HIV, which may help improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old.
- You must be able to give written consent and provide blood samples.
- If you have HIV, you must have never taken HIV medication (treatment-naive) and have fatty liver disease.
- If you don't have HIV, you must have fatty liver disease (or be a healthy control without fatty liver).
- You must not have severe liver disease (like decompensated cirrhosis or liver cancer), be pregnant or breastfeeding, or have other severe infections or organ failure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to understand the genetic factors behind metabolic fatty liver disease (MASLD) by comparing patients with advanced liver scarring or liver cancer to healthy blood donors. It may help doctors better predict and treat the disease in the future.
This study looks at a new non-invasive screening method to predict metabolic dysfunction–associated steatotic liver disease (MASLD), a condition where fat builds up in the liver. The goal is to help identify people who may be at risk without needing invasive tests.
This study tests whether adding a liver stiffness measurement to a lifestyle program helps people with MASLD (a type of fatty liver disease) improve their liver health. It is designed for people who have fatty liver and at least one sign of metabolic syndrome, like high blood pressure or diabetes.
This study looks at how common a certain type of fatty liver disease (called MASLD) is in adults with Type 1 diabetes. The goal is to learn more about liver health in people with Type 1 diabetes to help improve care.
This study tests if resmetirom can help people who have both HIV and a liver condition called MASLD (fat buildup in the liver not caused by alcohol). You may qualify if your liver has a certain amount of fat and stiffness, and your HIV is well controlled with stable medication.
This study looks at how the liver responds to sugar given through a vein in obese patients with and without a fatty liver condition called MASLD. It may help doctors understand why some people develop liver problems from sugar and fat.
Hear when a new MASLD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.